These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9717632)

  • 21. Ionic contrast media induced more apoptosis in diabetic kidney than nonionic contrast media.
    Lee HC; Chang JG; Yen HW; Liu IH; Lai WT; Sheu SH
    J Nephrol; 2011; 24(3):376-80. PubMed ID: 20890877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse reactions of low osmolar non-ionic and ionic contrast media when used together or separately during percutaneous coronary intervention.
    Juergens CP; Khaing AM; McIntyre GJ; Leung DY; Lo ST; Fernandes C; Hopkins AP
    Heart Lung Circ; 2005 Sep; 14(3):172-7. PubMed ID: 16352273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of the iodinated contrast agents Ioxaglate, Iohexol and Iodixanol on thrombus formation and fibrinolysis.
    Jones CI; Goodall AH
    Thromb Res; 2003; 112(1-2):65-71. PubMed ID: 15013276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotoxicity of hydrosoluble iodine contrast media.
    Caillé JM; Allard M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S210-2. PubMed ID: 3058631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red blood cell aggregability and contrast media. Recent results of quantitative dynamic ultrasonic analysis.
    Kallio T; Alanen A; Kormano M
    Invest Radiol; 1990 Sep; 25 Suppl 1():S121-2. PubMed ID: 2283228
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty.
    Piessens JH; Stammen F; Vrolix MC; Glazier JJ; Benit E; De Geest H; Willems JL
    Cathet Cardiovasc Diagn; 1993 Feb; 28(2):99-105. PubMed ID: 8448808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast-medium-induced ventricular fibrillation: arrhythmogenic mechanisms and the role of antiarrhythmic drugs in dogs.
    Idée JM; Matalon C; Koeltz B; Bonnemain B; Lefevre T
    Acad Radiol; 1996 Sep; 3(9):781-5. PubMed ID: 8883521
    [No Abstract]   [Full Text] [Related]  

  • 28. Site of action of contrast media on cerebral vessels.
    Edvinsson L; Golman K; Jansen I
    Cephalalgia; 1987 Jun; 7(2):83-5. PubMed ID: 3607870
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspirin and fraxiparine in the prevention of laser induced thrombosis in the presence of iodinated contrast media.
    Aguejouf O; Belougne Malfatti E; Doutremepuich F; Doutremepuich C
    Thromb Res; 1998 Nov; 92(3):105-13. PubMed ID: 9806362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombogenicity of ionic and nonionic contrast media tested in a laser induced rat thrombosis model.
    Aguejouf O; Doutremepuich F; Azougagh Oualane F; Doutremepuich C
    Thromb Res; 1995 Feb; 77(3):259-69. PubMed ID: 7740518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Miscellaneous adverse effects of low-versus high-osmolality contrast media: a study revised.
    Brismar J; Jacobsson BF; Jorulf H
    Radiology; 1991 Apr; 179(1):19-22. PubMed ID: 1826061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ionic or non-ionic contrast media during coronary intervention: does it make a difference?
    Legrand V
    Eur Heart J; 2001 Mar; 22(5):353-4. PubMed ID: 11207074
    [No Abstract]   [Full Text] [Related]  

  • 33. Pain in peripheral arteriography: an assessment of conventional versus ionic and non-ionic low-osmolality contrast agents.
    Murphy G; Campbell DR; Fraser DB
    Can Assoc Radiol J; 1988 Jun; 39(2):103-6. PubMed ID: 2967829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conclusion of recent 'osmolality trials' in preventing contrast-induced nephropathy by NAC--what is the standard?
    Jo SH; Koo BK; Youn TJ; Kim HS
    Nephrol Dial Transplant; 2008 Jul; 23(7):2424; author reply 2424-5. PubMed ID: 18445639
    [No Abstract]   [Full Text] [Related]  

  • 35. [Severe reactions to iodinated contrast agents: is anaphylaxis responsible?].
    Dewachter P; Mouton-Faivre C
    J Radiol; 2001 Sep; 82(9 Pt 1):973-7. PubMed ID: 11591924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrastructural evaluation of the effects of the contrast media on the rat kidney.
    Cağlar Y; Mete UO; Kaya M
    J Submicrosc Cytol Pathol; 2001 Oct; 33(4):443-51. PubMed ID: 11989778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulant effects of nonionic versus ionic contrast media in angiography syringes.
    Grabowski EF; Kaplan KL; Halpern EF
    Invest Radiol; 1991 May; 26(5):417-21. PubMed ID: 2055738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tolerability of a new non-ionic contrast medium, iopromide in x-ray computed tomography. Comparison with ioxaglate 320 mgI/ml].
    Fredy D; Heitz F; Mathieu D; Vasile N
    Ann Radiol (Paris); 1989; 32(4 Pt 2):358-60. PubMed ID: 2688533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of thrombosis during coronary angioplasty with low osmolality contrast media.
    Esplugas E; Cequier A; Jara F; Mauri J; Soler T; Sala J; Sabate X
    Am J Cardiol; 1991 Oct; 68(10):1020-4. PubMed ID: 1927914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assays for plasma complement activation by x-ray contrast media.
    Eaton S; Tsay HM; Yost F; Tweedle MF
    Invest Radiol; 1990 Jul; 25(7):789-92. PubMed ID: 2391195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.